RESUMEN
The objective was to describe French hospital nasal screening and decolonization procedures before clean surgery procedures. Information for participants was sent to the French Society for Infection Control members in June 2018. Seventy hospitals participated in the survey; 40% (N = 28) declared having institutional decolonization procedures: 64% (N = 18) in orthopaedic and 56% (N = 15) in cardiac surgeries. All hospitals used mupirocin for nasal decolonization and body decolonization with chlorhexidine (N = 16) or povidone iodine (N = 10). This study is the first to be performed in France giving information in this field. Screening/decolonization procedures are heterogeneous and the evaluation of their clinical impact remains complex.
Asunto(s)
Antibacterianos/administración & dosificación , Antiinfecciosos Locales/administración & dosificación , Portador Sano/microbiología , Descontaminación/métodos , Nariz/microbiología , Infecciones Estafilocócicas/prevención & control , Infección de la Herida Quirúrgica/prevención & control , Clorhexidina/administración & dosificación , Francia , Humanos , Control de Infecciones/métodos , Mupirocina/administración & dosificación , Procedimientos Ortopédicos/efectos adversos , Povidona Yodada/administración & dosificación , Investigación Cualitativa , Staphylococcus aureus , Encuestas y Cuestionarios , Procedimientos Quirúrgicos Torácicos/efectos adversosRESUMEN
INTRODUCTION: Survival of adolescents and young adults (AYA) with sarcoma is lower than in younger patients. The objective of this study was to describe the regional healthcare circuits, the differences in the management between adult, paediatric and mixed units and to assess the prognostic impact of compliance with clinical practice guidelines (CPGs) on overall survival (OS) and on relapse free survival (RFS). MATERIALS AND METHODS: Retrospective analysis of the management and long term follow-up of all 13-25 year old patients with a sarcoma diagnosed in the Rhône-Alpes area between 2000 and 2005. RESULTS: 140 patients satisfied inclusion criteria and were selected. The majority of 13-25 year old patients were treated in paediatric units. Joint management resulted in a higher rate of discussion in multidisciplinary tumour board, inclusion in clinical trials, and fertility preservation. Non-compliance with guidelines was observed in 65% of cases. Overall compliance was not reported to correlate to survival. Compliance of radiotherapy with CPG's seemed associated with a better prognosis for OS (HR = 0.20, 95% CI = [0.10-0.40]; p < 0.0001) and RFS (HR = 0.18, 95% CI = [0.09-0.37; p < 0.0001) as well as compliance of surgery for OS (HR = 0.43, 95% CI = [0.23-0.81]; p = 0.01). Multivariate Cox regression analysis revealed other independent predictors of OS like age at diagnosis, stage and histological subtype. CONCLUSIONS: Management of AYA in joint units seems to improve the quality of care. Compliance of surgery and radiotherapy with CGP's seems to improve survival.
Asunto(s)
Adhesión a Directriz , Sarcoma/patología , Sarcoma/terapia , Adolescente , Adulto , Factores de Edad , Supervivencia sin Enfermedad , Femenino , Estudios de Seguimiento , Francia , Humanos , Comunicación Interdisciplinaria , Masculino , Estadificación de Neoplasias , Grupo de Atención al Paciente , Guías de Práctica Clínica como Asunto , Radioterapia/normas , Estudios Retrospectivos , Procedimientos Quirúrgicos Operativos/normas , Tasa de Supervivencia , Adulto JovenRESUMEN
PURPOSE: To evaluate the Spot Vision Screener (SVS) compared with the orthoptic examination for detection of amblyopia risk factors in preschools. METHODS: This prospective study included children with a visual screening organized by the department of "le" (PMI) in Côte d'Or (Burgundy, France), between June 2017 and April 2018. All children were evaluated with the SVS followed by a clinical orthoptic examination. Results with the SVS were compared with those obtained by clinical orthoptic examination. RESULTS: A total of 1236 subjects were included in the study from 100 preschools. The mean age of the children was 3.6±0.7 years, and 627 were female (50.7%). The orthoptic examination detected 308 (24.9%) children with subnormal visual acuity for age in one eye or both. In children with a history of prematurity, the orthoptic examination was more frequently abnormal (P=0.002), which was not seen with the SVS (P=0.050). The SVS screened 20 (1.6%) children with strabismus, while 40 (3.2%) were detected by orthoptic examination. At the end of the screening, the SVS detected 182 (14.7%) suspect patients while 311 (25.1%) suspect patients were detected after the orthoptic examination. Comparing SVS with orthoptic examination, agreement was fair (κ=0.4). CONCLUSION: The SVS can be a useful device for visual screening, but agreement with the orthoptic examination was only fair. The Spot vision screener should be used in conjunction with a clinical orthoptic examination.
Asunto(s)
Ortóptica/métodos , Escuelas de Párvulos , Selección Visual/métodos , Ambliopía/diagnóstico , Ambliopía/epidemiología , Preescolar , Femenino , Francia/epidemiología , Humanos , Masculino , Tamizaje Masivo/métodos , Examen Físico , Estudios Prospectivos , Refracción Ocular/fisiología , Factores de Riesgo , Servicios de Salud Escolar/estadística & datos numéricos , Escuelas de Párvulos/estadística & datos numéricos , Estrabismo/diagnóstico , Estrabismo/epidemiología , Agudeza VisualRESUMEN
The increase use of immunosuppressive treatments in patients with solid cancer and/or inflammatory diseases requires revisiting our practices for the prevention of infectious risk in the care setting. A review of the literature by a multidisciplinary working group at the beginning of 2014 wished to answer the following 4 questions to improve healthcare immunocompromised patients: (I) How can we define immunocompromised patients with high, intermediate and low infectious risk, (II) which air treatment should be recommended for this specific population? (III) What additional precautions should be recommended for immunocompromised patients at risk for infection? (IV) Which global environmental control should be recommended? Based on data from the literature and using the GRADE method, we propose 15 recommendations that could help to reduce the risk of infection in these exposed populations.
Asunto(s)
Huésped Inmunocomprometido , Control de Infecciones , Infecciones , Microbiología del Aire , Susceptibilidad a Enfermedades , Francia , Humanos , Guías de Práctica Clínica como Asunto , Factores de RiesgoRESUMEN
OBJECTIVE: To correlate dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) features to clinical and computed tomography (CT) morphological features of osteoid osteoma (OO). MATERIALS AND METHODS: Our institutional review board approved this retrospective study, waiving the need for informed consent. We included the 102 patients treated with interstitial laser ablation for histologically documented OO at our institution in 2008-2013. DCE-MRI variables were the time-enhancement pattern and rising slope (Sloperise) and CT variables were the bone and segment involved (OObone and OOsegment, respectively), OO location relative to the native cortex (OOcortex), nidus surface area, vessel sign, and largest neighboring-vessel diameter (Dmaxvessel). Descriptive statistics and correlations linking DCE-MRI findings to clinical and CT characteristics were computed. RESULTS: DCE-MRI showed early arterial peak enhancement in 95 (93%) cases, with a mean Sloperise of 9.30 ± 8.10. CT visualized a vessel sign in 84 (82%) cases with a mean Dmaxvessel of 1.10 ± 0.60 mm. By univariate analysis, Sloperise correlated significantly with pain duration and Dmaxvessel (r = 0.30, P = 0.003; and r = 0.22, P = 0.03; respectively). Analysis of variance showed that Sloperise correlated significantly with OObone (P < 0.001), with a steeper slope for OOs located in short or flat bones. CONCLUSION: This study suggests more abundant vascularization of OOs with long-lasting pain and location on short or flat bones.
Asunto(s)
Neoplasias Óseas/diagnóstico por imagen , Imagen por Resonancia Magnética/métodos , Osteoma Osteoide/diagnóstico por imagen , Tomografía Computarizada por Rayos X/métodos , Adolescente , Adulto , Niño , Medios de Contraste , Femenino , Humanos , Interpretación de Imagen Asistida por Computador , Masculino , Persona de Mediana Edad , Estudios RetrospectivosRESUMEN
Group A rotavirus (RVA) is the leading cause of acute gastroenteritis in young children worldwide. A prospective surveillance network has been set up to investigate the virological and clinical features of RVA infections and to detect the emergence of potentially epidemic strains in France. From 2009 to 2014, RVA-positive stool samples were collected from 4800 children <5 years old attending the paediatric emergency units of 16 large hospitals. Rotaviruses were then genotyped by RT-PCR with regard to their outer capsid proteins VP4 and VP7. Genotyping of 4708 RVA showed that G1P[8] strains (62.2%) were predominant. The incidence of G9P[8] (11.5%), G3P[8] (10.4%) and G2P[4] (6.6%) strains varied considerably, whereas G4P[8] (2.7%) strains were circulating mostly locally. Of note, G12P[8] (1.6%) strains emerged during the seasons 2011-12 and 2012-13 with 4.1% and 3.0% prevalence, respectively. Overall, 40 possible zoonotic reassortants, such as G6 (33.3%) and G8 (15.4%) strains, were detected, and were mostly associated with P[6] (67.5%). Analysis of clinical records of 624 hospitalized children and severity scores from 282 of them showed no difference in clinical manifestations or severity in relation to the genotype. The relative stability of RVA genotypes currently co-circulating and the large predominance of P[8] type strains may ensure vaccine effectiveness in France. The surveillance will continue to monitor the emergence of new reassortants that might not respond to current vaccines, all the more so as all genotypes can cause severe infections in infants.
Asunto(s)
Enfermedades Transmisibles Emergentes , Servicio de Urgencia en Hospital , Infecciones por Rotavirus/epidemiología , Infecciones por Rotavirus/virología , Rotavirus/genética , Animales , Preescolar , Heces/virología , Femenino , Francia/epidemiología , Genotipo , Humanos , Lactante , Recién Nacido , Masculino , Filogenia , Prevalencia , Virus Reordenados , Rotavirus/clasificación , Rotavirus/aislamiento & purificación , Infecciones por Rotavirus/diagnóstico , Estaciones del Año , Índice de Severidad de la EnfermedadRESUMEN
Noroviruses (NoVs) constitute a major cause of gastroenteritis in Tunisia. One hundred and fourteen matched saliva and stool samples were collected from children (n = 114) suffering from acute gastroenteritis at the hospital of Monastir during the winter season 2011-2012. For 98 of 114 children, blood samples were collected for secretor genotyping. NoVs were associated with 36.8% (n = 42/114) of the gastroenteritis cases. The GII.3 genotype was the most common (69% of all NoVs). For patients who were phenotyped (n = 114) for human blood group antigens (HBGAs), the secretor and non-secretor phenotypes represented 79% and 21%, respectively. Of the NoV infections, 83% were detected in all ABO groups. Five GII.3 isolates, one GII.1 isolate and one GII.7 isolate were detected in Lewis-positive non-secretors, confirmed by genotyping of the FUT2 gene. Even though our data showed that GII.3 NoVs could infect non-secretors, no binding was observed with saliva and GII.3 baculovirus-expressed virus-like particles from the same symptomatic non-secretor individual. This suggests that other factors might also participate in NoV attachment in children and newborns.
Asunto(s)
Antígenos de Grupos Sanguíneos , Infecciones por Caliciviridae/epidemiología , Infecciones por Caliciviridae/virología , Genotipo , Norovirus/clasificación , Norovirus/aislamiento & purificación , Preescolar , Gastroenteritis/epidemiología , Gastroenteritis/virología , Hospitales , Humanos , Lactante , Norovirus/genética , Túnez/epidemiología , Acoplamiento ViralAsunto(s)
Descontaminación/métodos , Control de Infecciones/métodos , Cuidados Preoperatorios/métodos , Infecciones Estafilocócicas/prevención & control , Staphylococcus aureus/efectos de los fármacos , Infección de la Herida Quirúrgica/prevención & control , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Antiinfecciosos Locales/uso terapéutico , Portador Sano , Humanos , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Staphylococcus aureus Resistente a Meticilina/aislamiento & purificación , Gestión de Riesgos , Staphylococcus aureus/aislamiento & purificaciónRESUMEN
OBJECTIVES: To estimate the internal consistency, test-retest reliability and comparability of paper and computer versions of the Finnish version of the Tampa Scale of Kinesiophobia (TSK-FIN) among patients with chronic pain. In addition, patients' personal experiences of completing both versions of the TSK-FIN and preferences between these two methods of data collection were studied. DESIGN: Test-retest reliability study. Paper and computer versions of the TSK-FIN were completed twice on two consecutive days. PARTICIPANTS: The sample comprised 94 consecutive patients with chronic musculoskeletal pain participating in a pain management or individual rehabilitation programme. The group rehabilitation design consisted of physical and functional exercises, evaluation of the social situation, psychological assessment of pain-related stress factors, and personal pain management training in order to regain overall function and mitigate the inconvenience of pain and fear-avoidance behaviour. RESULTS: The mean TSK-FIN score was 37.1 [standard deviation (SD) 8.1] for the computer version and 35.3 (SD 7.9) for the paper version. The mean difference between the two versions was 1.9 (95% confidence interval 0.8 to 2.9). Test-retest reliability was 0.89 for the paper version and 0.88 for the computer version. Internal consistency was considered to be good for both versions. The intraclass correlation coefficient for comparability was 0.77 (95% confidence interval 0.66 to 0.85), indicating substantial reliability between the two methods. CONCLUSION: Both versions of the TSK-FIN demonstrated substantial intertest reliability, good test-retest reliability, good internal consistency and acceptable limits of agreement, suggesting their suitability for clinical use. However, subjects tended to score higher when using the computer version. As such, in an ideal situation, data should be collected in a similar manner throughout the course of rehabilitation or clinical research.
Asunto(s)
Dolor Crónico/diagnóstico , Dolor Crónico/rehabilitación , Diagnóstico por Computador , Quinesiología Aplicada/métodos , Encuestas y Cuestionarios , Adulto , Anciano , Intervalos de Confianza , Femenino , Finlandia , Humanos , Masculino , Persona de Mediana Edad , Papel , Psicometría , Reproducibilidad de los Resultados , Índice de Severidad de la EnfermedadRESUMEN
Small supernumerary marker chromosomes (sSMCs) are structurally abnormal chromosomes that cannot be characterized by karyotype. In many prenatal cases of de novo sSMC, the outcome of pregnancy is difficult to predict because the euchromatin content is unclear. This study aimed to determine the presence or absence of euchromatin material of 39 de novo prenatally ascertained sSMC by array-comparative genomic hybridization (array-CGH) or single nucleotide polymorphism (SNP) array. Cases were prospectively ascertained from the study of 65,000 prenatal samples [0.060%; 95% confidence interval (CI), 0.042-0.082]. Array-CGH showed that 22 markers were derived from non-acrocentric markers (56.4%) and 7 from acrocentic markers (18%). The 10 additional cases remained unidentified (25.6%), but 7 of 10 could be further identified using fluorescence in situ hybridization; 69% of de novo sSMC contained euchromatin material, 95.4% of which for non-acrocentric markers. Some sSMC containing euchromatin had a normal phenotype (31% for non-acrocentric and 75% for acrocentric markers). Statistical differences between normal and abnormal phenotypes were shown for the size of the euchromatin material (more or less than 1 Mb, p = 0.0006) and number of genes (more or less than 10, p = 0.0009). This study is the largest to date and shows the utility of array-CGH or SNP array in the detection and characterization of de novo sSMC in a prenatal context.
Asunto(s)
Aberraciones Cromosómicas , Asesoramiento Genético , Predisposición Genética a la Enfermedad , Pronóstico , Adulto , Hibridación Genómica Comparativa , Femenino , Francia , Estudios de Asociación Genética , Marcadores Genéticos , Estudio de Asociación del Genoma Completo , Humanos , Hibridación Fluorescente in Situ , Cariotipo , Persona de Mediana Edad , Polimorfismo de Nucleótido Simple , Embarazo , Diagnóstico Prenatal , Estudios Prospectivos , Riesgo , Suiza , Adulto JovenRESUMEN
PURPOSE: The purpose of our study is to determine whether there is a relation between overweight, age, sex, "hospitalised/outpatient" status and a non-inflammatory hypersignal of the subcutaneous lumbosacral adipose tissue in T2 Short-Tau Inversion-Recovery (T2-STIR) MR imaging sequences. PATIENTS AND METHODS: One hundred and six lumbar MRI, including a T2-STIR and T1 Fluid Attenuated Inversion-Recovery (FLAIR) weighted sagittal sequences, were retrospectively taken from the picture archiving and communication system (PACS) of our hospital and then made anonymous and analysed. The presence or absence of a T2-STIR hypersignal within subcutaneous adipose tissue behind the paraspinal muscle aponeurosis was determined. In addition, the weight, thickness of the fat tissue, the administrative status of the patient, the age, sex, time of the examination and, when present, the height of this hypersignal were noted. A uni- and multivariate analysis by logistic regression was carried out in order to examine the relationship between the data gathered. RESULTS: In the examinations selected, 25.5% (n=27) demonstrated a T2-STIR hypersignal in the subcutaneous tissue. We identified the weight (P<0.023), thickness of the fat tissue (P<0.001), the age of the patient (P<0.017) and the "hospitalised" status (P<0.009) as significant variables associated with this T2-STIR hypersignal. The mean height of the hypersignal was 109.5mm. Five of the 27 patients had an injection of gadolinium chelate and no enhancement was found at this level. CONCLUSION: We found a significant link between overweight, age and "hospitalised" status and the non-inflammatory infiltration of lumbar adipose tissue. This phenomenon seems to correspond with an interstitial oedema, related to subcutaneous stasis. This anomaly should not be confused with a local inflammation.
Asunto(s)
Artefactos , Aumento de la Imagen , Interpretación de Imagen Asistida por Computador , Vértebras Lumbares/patología , Obesidad/patología , Sacro/patología , Enfermedades de la Columna Vertebral/diagnóstico , Grasa Subcutánea/patología , Factores de Edad , Atención Ambulatoria , Edema/diagnóstico , Femenino , Hospitalización , Humanos , Masculino , Persona de Mediana Edad , Sistemas de Información Radiológica , Sensibilidad y Especificidad , Programas InformáticosRESUMEN
BACKGROUND: The surveillance of methicillin-resistant Staphylococcus aureus (MRSA) is a national priority. The rate of MRSA infections is one of six indicators tracked by the Department of Health. Since 2002, the French institute for public health surveillance (InVS) has monitored MRSA infections to estimate incidence density. Today, the use of the French administrative database (PMSI) could facilitate this surveillance. The aim of this study was to compare MRSA incidence density computed at a national level using PMSI databases with the results from the InVS taken as the reference. METHODS: PMSI databases for the years 2006 to 2009 were used. The reference results were those published by the InVS from 2006 to 2009. MRSA density defined as the number of MRSA infections recorded per year over 1000 hospital stays was computed. It was then compared with the MRSA incidence density measured by InVS. The time course of MRSA incidence in the PMSI records was modeled using a Poisson regression. RESULTS: The incidence density measured by the InVS was higher than the MRSA density computed using the PMSI, but this difference appeared to decrease over time. The PMSI density/InVS MRSA incidence density ratio was 0.8% in 2006 and about 9.2% in 2009. We observed inverted trends with a growing trend in MRSA density identified by the PMSI. Furthermore, the year of study was significantly associated with incidence density (P=0.01). CONCLUSION: Using PMSI data as an additional source of information in the hospital MRSA surveillance process makes it possible to detect and analyze patient repeats at the regional and national levels with linkage facilities. Estimation of incidence density for hospitals not participating to this surveillance system will be the next step.
Asunto(s)
Bases de Datos Factuales/estadística & datos numéricos , Grupos Diagnósticos Relacionados/estadística & datos numéricos , Sistemas de Registros Médicos Computarizados/estadística & datos numéricos , Staphylococcus aureus Resistente a Meticilina , Vigilancia de la Población/métodos , Infecciones Estafilocócicas/epidemiología , Análisis por Conglomerados , Infección Hospitalaria/epidemiología , Bases de Datos Factuales/normas , Francia/epidemiología , Hospitales/normas , Hospitales/estadística & datos numéricos , Humanos , Incidencia , Tiempo de Internación/estadística & datos numéricos , Sistemas de Registros Médicos Computarizados/normas , Infecciones Estafilocócicas/economíaRESUMEN
Profilaggrin (proFLG) and its processing products are critical to the health and appearance of skin. The recent identification of loss-of-function filaggrin (FLG) mutations as a predisposing factor in ichthyosis vulgaris and atopic dermatitis has lead to a resurgent interest in this enigmatic protein. Here, we review the literature on the structure and many functions of proFLG, from its role as a filament-aggregating protein and a source of natural moisturizing factor (NMF), to the more recent discoveries of its role in epidermal barrier formation and its more speculative functions as an antimicrobial and sunscreen. Finally, we discuss the relationship of proFLG with dry skin, the influence of moisturizers on NMF generation and speculate on next generation of FLG research.
Asunto(s)
Proteínas de Filamentos Intermediarios/metabolismo , Enfermedades de la Piel/metabolismo , Piel/metabolismo , Animales , Epidermis/metabolismo , Proteínas Filagrina , HumanosRESUMEN
The purpose of this study is to evaluate the prevalence of musculoskeletal pain and the use of analgesics in two random cohorts of home-dwelling older people 10 years apart (1999 (N = 2044) and 2009 (N = 1610)) in Helsinki, Finland, and to explore which patients characteristics are associated with potential undertreatment or overtreatment of pain. In 1999, the prevalence of daily joint pain interfering with functioning was 16.4% and that of back pain 13.9% among 75-85-year-old people, the respective figures being 21.9% and 17.1% in 2009 (p < 0.001). The proportion of those patients suffering from joint pain and using prescribed analgesics for that was 35.5% in 1999 and 41.5% in 2009 (p < 0.001). The corresponding figures for patients suffering from back pain with analgesics were 38.2% and 48.2% (p < 0.001), respectively. In 2009, 66.1% suffered from any musculoskeletal pain and 28.7% of them were prescribed analgesics, the figures being more frequent among women than men. In addition to higher age, female gender, and painful conditions, also psychiatric symptoms and dizziness tended to be independently associated with analgesic prescriptions. Among persons not reporting pain (N = 545) psychiatric symptoms were overrepresented in the group using prescribed analgesics (22.4% vs. 8.1%, p < 0.05). In conclusion, musculoskeletal pain is still clearly undertreated, but the coverage has increased during 10 years. In addition to pain, several patient characteristics, functioning and psychiatric symptoms, especially, were associated with analgesic prescriptions.
Asunto(s)
Analgésicos/uso terapéutico , Dolor Musculoesquelético/epidemiología , Factores de Edad , Anciano , Anciano de 80 o más Años , Femenino , Finlandia/epidemiología , Humanos , Modelos Logísticos , Masculino , Dolor Musculoesquelético/tratamiento farmacológico , Medicamentos sin Prescripción/uso terapéutico , Medicamentos bajo Prescripción/uso terapéutico , Prevalencia , Factores Sexuales , Encuestas y CuestionariosRESUMEN
PURPOSE: The aim of our study was to assess the results and cost of a treatment strategy involving transarterial chemoembolisation with drug eluting beads (DEB-TACE) in patients with unresectable non-metastatic hepatocellular carcinoma (HCC). PATIENTS AND METHODS: This study included all patients treated with DEB-TACE in our hospital between January 2009 and December 2010. All patients received DEB-TACE on demand and were evaluated after each session. RESULTS: Twenty-one patients received an average of 1.3 sessions. The median time to treatment discontinuation and median progression-free survival was 181 days and 295 days, respectively. Toxicity caused treatment discontinuation in three patients (14%). For the hospital, the average direct cost of treatment was 6,033 according to the analytical accounting system vs. 4,558 according to the official tariffs from the new French Diagnosis-Related Group prospective payment system (P=0.002). CONCLUSION: In the treatment of HCC, on-demand DEB-TACE stabilises the disease in some patients but has not yet been thoroughly evaluated.
Asunto(s)
Carcinoma Hepatocelular/tratamiento farmacológico , Carcinoma Hepatocelular/economía , Quimioembolización Terapéutica/economía , Sistemas de Liberación de Medicamentos/economía , Neoplasias Hepáticas/tratamiento farmacológico , Neoplasias Hepáticas/economía , Anciano , Anciano de 80 o más Años , Costos y Análisis de Costo , Femenino , Humanos , Masculino , Microesferas , Persona de Mediana Edad , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
OBJECTIVE OF THE STUDY: Study of the spatio-temporal fungal colonization in a new medical mycology laboratory. METHODS: A 17-month survey of airborne fungal contamination was conducted in a new medical mycology laboratory at a tertiary care university hospital. This survey was implemented at three different periods: before the new premises were occupied (period A), during the move into the new laboratory (period B) and after resumption of the mycological activities in these new premises (period C). RESULTS: During period A, the airborne fungal load ranged from 2.3 to 6 cfu/m(3). The most frequently recovered airborne fungi were Penicillium spp. (75 to 100%). During period B, a dramatic increase in Penicillium chrysogenum conidia was observed in the air of the new laboratory (40 to 160 cfu/m(3)). During period C, the fungal load ranged from 4.5 to 8.4 cfu/m(3). Penicillium was the most common genus identified in rooms of the laboratory where no filamentous fungi were handled, while Aspergillus was clearly the predominant genus (78%) in the room dedicated to the culture of filamentous fungi. CONCLUSIONS: We suggest that the specific fungal ecology in air of the room dedicated to the culture of filamentous fungi is due to the handling of a large number of medical strains of A. fumigatus.
Asunto(s)
Microbiología del Aire , Hongos/crecimiento & desarrollo , Laboratorios de Hospital , Micología , Aspergillus/crecimiento & desarrollo , Aspergillus/aislamiento & purificación , Recuento de Colonia Microbiana , Monitoreo del Ambiente , Unidades Hospitalarias , Humanos , Laboratorios de Hospital/normas , Micología/normas , Penicillium/crecimiento & desarrollo , Penicillium/aislamiento & purificaciónRESUMEN
In Egypt, the disease burden of viral hepatitis is one of the heaviest worldwide. We conducted a survey of hepatitis A virus (HAV) and hepatitis E virus (HEV) in patients and sewage in Cairo. Our data showed that HAV (genotype IB) was predominant over HEV (genotype 3) and was circulating in the population and the environment.
Asunto(s)
Virus de la Hepatitis A/aislamiento & purificación , Hepatitis A/epidemiología , Virus de la Hepatitis E/aislamiento & purificación , Hepatitis E/epidemiología , Aguas del Alcantarillado/virología , Adolescente , Bilirrubina/análisis , Niño , Preescolar , Egipto/epidemiología , Genotipo , Hepatitis A/virología , Virus de la Hepatitis A/genética , Hepatitis E/virología , Virus de la Hepatitis E/genética , Humanos , Lactante , ARN Viral/análisis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Carga ViralRESUMEN
Noroviruses (NoVs) are one of the leading causes of gastroenteritis in children and adults. For the last 2 decades, genogroup II genotype 4 (GII.4) NoVs have been circulating worldwide. GII.4 NoVs can be divided into variants, and since 2002 they have circulated in the population before being replaced every 2 or 3 years, which raises questions about the role of their histo-blood group antigen (HBGA) ligands in their evolution. To shed light on these questions, we performed an analysis of the interaction between representative GII.4 variants and HBGAs, and we determined the role of selected amino acids in the binding profiles. By mutagenesis, we showed that there was a strict structural requirement for the amino acids, directly implicated in interactions with HBGAs. However, the ablation of the threonine residue at position 395 (ΔT395), an epidemiological feature of the post-2002 variants, was not deleterious to the binding of the virus-like particle (VLP) to the H antigen, while binding to A and B antigens was severely hampered. Nevertheless, the ΔT395 VLPs gained the capacity to bind to the Lewis x and sialyl-Lewis x antigens in comparison with the wild-type VLP, demonstrating that amino acid residues outside the HBGA binding site can modify the binding properties of NoVs. We also analyzed the attachment of baculovirus-expressed VLPs from six variants (Bristol, US95/96, Hunter, Yerseke, Den Haag, and Osaka) that were isolated from 1987 to 2007 to phenotyped saliva samples and synthetic HBGAs. We showed that the six variants could all attach to saliva of secretors irrespective of the ABO phenotype and to oligosaccharides characteristic of the secretor phenotype. Interestingly, Den Haag and Osaka variants additionally bound to carbohydrates present in the saliva of Lewis-positive nonsecretors. The carbohydrate binding profile and the genetic and mutagenesis analysis suggested that GII.4 binding to Lewis x and sialyl-Lewis x antigens might be a by-product of the genetic variation of the amino acids located in the vicinity of the binding site. Analysis of the binding properties for the six variants by surface plasmon resonance showed that only post-2002 variants (i.e., Hunter, Yerseke, Den Haag, and Osaka) presented strong binding to A and B antigens, suggesting that the GII.4 evolution could be related to an increased affinity for HBGAs for the post-2002 variants. The combination of increased affinity for ABH antigens and of a newly acquired ability to recognize glycans from Lewis-positive nonsecretors could have contributed to the epidemiological importance of strains such as the Den Haag GII.4 subtype.
Asunto(s)
Antígenos de Grupos Sanguíneos/metabolismo , Norovirus/patogenicidad , Receptores Virales/metabolismo , Acoplamiento Viral , Evolución Molecular , Genotipo , Humanos , Proteínas Mutantes/genética , Proteínas Mutantes/metabolismo , Mutación , Unión Proteica , Resonancia por Plasmón de Superficie , Proteínas Virales/genética , Proteínas Virales/metabolismoRESUMEN
The aim of this study was to investigate the risk factors associated with CTX-M-producing Escherichia coli strains isolated from infected or colonized patients. From 191 clinical samples, a case-control study was designed. From January 2005 to December 2007, 98 hospitalized patients infected or colonized with CTX-M-producing E. coli were included in the study. They were matched 1 : 1 with controls that had a non-CTX-M-producing E. coli infection on the basis of the site of sample, the unit of hospitalization and the time at risk. The rate of CTX-M-producing E. coli among those producing extended spectrum ß-lactamases was always ≥90% from 2005 to 2008. All strains were susceptible to carbapenems. However, we observed a high rate of co-resistance to ciprofloxacin (61%), sulphonamides (86%) and gentamicin (34%). Significant risk factors identified by multivariate analysis were recurrent infections (OR = 2.93), presence of artificial nutrition (OR = 3.99), and recent exposure to quinolones (OR = 4.39), third- or fourth-generation cephalosporin (OR = 3.49) and the combination of both antibiotic classes (OR = 5.50). This report highlights the dramatic increase of CTX-M-producing E. coli and the need for changes in the use of antimicrobial drugs and in infection control measures to manage this major health concern.